Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jns.2020.117019 http://scihub22266oqcxt.onion/10.1016/j.jns.2020.117019 32679347!7347314!32679347     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32679347&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Neurol+Sci 2020 ; 416 (ä): 117019 Nephropedia Template TP {{tp|p=32679347|t=2020. Posterior reversible encephalopathy syndrome in patients with COVID-19 |pdf=|usr=}}{{32679347}} gab.com Text Posterior reversible encephalopathy syndrome in patients with COVID-19 JO: J Neurol Sci http://www.kidney.de/pget.php?&tw=1&pmid=32679347 #FOAvip OBJECTIVE: To report four patients with coronavirus disease 2019 (COVID-19) who developed posterior reversible encephalopathy syndrome (PRES). METHODS: Patient data was abstracted from medical records at Weill Cornell Medical Center. RESULTS: Four patients with SARS-CoV-2 infection and PRES were identified. The patients' ages ranged from 64 to 74 years, and two were women. All four patients were admitted to the hospital with acute respiratory distress syndrome requiring intensive care unit admission and mechanical ventilation. PRES was diagnosed after persistent confusion, lethargy, new focal neurological deficits, or seizures were noted, with evidence of seizures on electroencephalogram for two of the patients. Imaging confirmed the presence of cerebral vasogenic edema. All four patients had elevated blood pressure and renal injury in the days preceding PRES diagnosis, as well as evidence of systemic inflammation and systemic hypercoagulability. Symptoms of PRES improved with blood pressure control. CONCLUSIONS: Our four cases demonstrate the occurrence of PRES in critically-ill patients with COVID-19. PRES should be considered in the differential for acute neurological deficits and seizures in this setting. Twit Text FOAVip Posterior reversible encephalopathy syndrome in patients with COVID-19 ????J Neurol Sci http://www.kidney.de/pget.php?&tw=1&pmid=32679347 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32679347 #FOAvip English Wikipedia <ref>{{Cite pmid|32679347}}</ref> Posterior reversible encephalopathy syndrome in patients with COVID-19 #MMPMID32679347 Parauda SC; Gao V; Gewirtz AN; Parikh NS; Merkler AE; Lantos J; White H; Leifer D; Navi BB; Segal AZ J Neurol Sci 2020[Sep]; 416 (ä): 117019 PMID32679347show ga OBJECTIVE: To report four patients with coronavirus disease 2019 (COVID-19) who developed posterior reversible encephalopathy syndrome (PRES). METHODS: Patient data was abstracted from medical records at Weill Cornell Medical Center. RESULTS: Four patients with SARS-CoV-2 infection and PRES were identified. The patients' ages ranged from 64 to 74 years, and two were women. All four patients were admitted to the hospital with acute respiratory distress syndrome requiring intensive care unit admission and mechanical ventilation. PRES was diagnosed after persistent confusion, lethargy, new focal neurological deficits, or seizures were noted, with evidence of seizures on electroencephalogram for two of the patients. Imaging confirmed the presence of cerebral vasogenic edema. All four patients had elevated blood pressure and renal injury in the days preceding PRES diagnosis, as well as evidence of systemic inflammation and systemic hypercoagulability. Symptoms of PRES improved with blood pressure control. CONCLUSIONS: Our four cases demonstrate the occurrence of PRES in critically-ill patients with COVID-19. PRES should be considered in the differential for acute neurological deficits and seizures in this setting. |Aged[MESH] |COVID-19/*complications[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Posterior Leukoencephalopathy Syndrome/*complications[MESH]Posterior reversible encephalopathy syndrome in patients with COVID-19(epmc).pdf DeepDyve Pubget Overpricing